VolitionRx’s Nu.Q Cancer Test targets multi-billion-dollar liquid biopsy market
VolitionRx’s Nu.Q Cancer Test is transforming liquid biopsy diagnostics, offering a non-invasive, cost-effective blood test for early cancer detection. Read More
Prostate cancer diagnosis: A breakthrough in non-invasive testing
Prostate cancer is one of the most prevalent cancers affecting men globally, ranking sixth in occurrence after cancers of the lung, stomach, liver, colon, and ... Read More
Metropolis Healthcare acquires Core Diagnostics to lead in cancer testing
Metropolis Healthcare Limited, a leading name in India’s pathology sector, has announced the acquisition of Core Diagnostics, marking a transformative step towards becoming the nation’s ... Read More